CD44 plays a role in the pathogenesis of intestinal diseases, and differential expression of secretory mucin MUC5AC enhances tumorigenesis and confers chemotherapy resistance through the CD44/β-catenin/p53/p21 signaling pathway (Pothuraju et al., 2020). This evidence concerns the gene TP53 and intestinal disorder.